211 related articles for article (PubMed ID: 32518288)
1. An anticonvulsive drug, valproic acid (valproate), has effects on the biosynthesis of fatty acids and polyketides in microorganisms.
Poolchanuan P; Unagul P; Thongnest S; Wiyakrutta S; Ngamrojanavanich N; Mahidol C; Ruchirawat S; Kittakoop P
Sci Rep; 2020 Jun; 10(1):9300. PubMed ID: 32518288
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids.
Silva MF; Ruiter JP; IJlst L; Jakobs C; Duran M; de Almeida IT; Wanders RJ
Chem Biol Interact; 2001 Sep; 137(3):203-12. PubMed ID: 11566289
[TBL] [Abstract][Full Text] [Related]
3. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
[TBL] [Abstract][Full Text] [Related]
4. Molecular and therapeutic potential and toxicity of valproic acid.
Chateauvieux S; Morceau F; Dicato M; Diederich M
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798865
[TBL] [Abstract][Full Text] [Related]
5. Valproate potentiates androgen biosynthesis in human ovarian theca cells.
Nelson-DeGrave VL; Wickenheisser JK; Cockrell JE; Wood JR; Legro RS; Strauss JF; McAllister JM
Endocrinology; 2004 Feb; 145(2):799-808. PubMed ID: 14576182
[TBL] [Abstract][Full Text] [Related]
6. Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels.
Jadhav S; Russo S; Cottier S; Schneiter R; Cowart A; Greenberg ML
J Biol Chem; 2016 Oct; 291(42):22253-22261. PubMed ID: 27590340
[TBL] [Abstract][Full Text] [Related]
7. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
8. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.
Romoli M; Mazzocchetti P; D'Alonzo R; Siliquini S; Rinaldi VE; Verrotti A; Calabresi P; Costa C
Curr Neuropharmacol; 2019; 17(10):926-946. PubMed ID: 30592252
[TBL] [Abstract][Full Text] [Related]
9. Does Valproic Acid/Na Valproate Suppress Auditory Startle Reflex in Patients With Epilepsy?
Kızıltan ME; Leba LK; Gündüz A; Pazarcı N; Özkara Ç; Yeni N
Clin EEG Neurosci; 2018 Nov; 49(6):407-413. PubMed ID: 29262725
[TBL] [Abstract][Full Text] [Related]
10. Hidden pharmacological activities of valproic acid: A new insight.
Singh D; Gupta S; Verma I; Morsy MA; Nair AB; Ahmed AF
Biomed Pharmacother; 2021 Oct; 142():112021. PubMed ID: 34463268
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
Löscher W; Nau H; Marescaux C; Vergnes M
Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
Semmes RL; Shen DD
Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
[TBL] [Abstract][Full Text] [Related]
13. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
Fujiki R; Sato A; Fujitani M; Yamashita T
Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH
Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic induction of melatonin MT
Bahna SG; Niles LP
Eur Neuropsychopharmacol; 2017 Aug; 27(8):828-832. PubMed ID: 28648552
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
[TBL] [Abstract][Full Text] [Related]
17. Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids.
Płonka-Półtorak E; Zagrodzki P; Kryczyk-Kozioł J; Westermarck T; Kaipainen P; Kaski M; Atroshi F
Pharmacol Rep; 2016 Dec; 68(6):1339-1344. PubMed ID: 27701058
[TBL] [Abstract][Full Text] [Related]
18. Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes.
Yuyama M; Fujimori K
Biochem J; 2014 May; 459(3):489-503. PubMed ID: 24511897
[TBL] [Abstract][Full Text] [Related]
19. The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.
Chang P; Orabi B; Deranieh RM; Dham M; Hoeller O; Shimshoni JA; Yagen B; Bialer M; Greenberg ML; Walker MC; Williams RS
Dis Model Mech; 2012 Jan; 5(1):115-24. PubMed ID: 21876211
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gut microbiota in patients with epilepsy treated with valproate: Results from a three months observational prospective cohort study.
Gong X; Liu Y; Liu X; Li AQ; Guo KD; Zhou D; Hong Z
Microb Pathog; 2022 Jan; 162():105340. PubMed ID: 34883229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
